XIX International AIDS Conference

Pharmacokinetics, safety and antiviral activity of fosamprenavir/ritonavir-containing regimens in HIV-positive four weeks to < two year-old children (48-week data, study APV20002, a prospective, open-label, multi-centre, 48-week cohort study) TUAB0202

Time: 11:15
Speaker: Jorg Sievers

This text willreplaced

You can download the video file here

For more information on this presentation, including access to speaker presentations, please see the conference Programme-at-a-Glance page.

Contact Us | Site map © 2012 International AIDS Society